Research Success

Spark Therapeutics announces positive top-line results in Phase III of an ongoing clinical trial restoring partial sight in participants. Read about it here.

In this Eye on the Cure blog post, FFB’s chief research officer, Dr. Steve Rose, explains how just how significant ongoing success in Spark Therapeutics’ clinical trial is.

“Restoring Sight, One Treatment at a Time” is a video telling the story of Allison Corona, a young woman who participated in the Spark Therapeutics trial and regained enough of her eyesight to start life anew.